Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C12H11I3N2O4.C7H17NO5 |
Molecular Weight | 823.1537 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CC(=O)NCC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I
InChI
InChIKey=UYIPQECISAQMIU-WZTVWXICSA-N
InChI=1S/C12H11I3N2O4.C7H17NO5/c1-4(18)16-3-6-8(13)7(12(20)21)10(15)11(9(6)14)17-5(2)19;1-8-2-4(10)6(12)7(13)5(11)3-9/h3H2,1-2H3,(H,16,18)(H,17,19)(H,20,21);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1
DescriptionSources: http://www.drugfuture.com/mt/meglumine-iodamide.pdf
Sources: http://www.drugfuture.com/mt/meglumine-iodamide.pdf
Iodamide is an ionic monomeric iodinated radiographic contrast medium. It was used in many procedures and may be given intravenously or by other routes, for example by instillation into the bladder or uterus; it has also been used for computed tomography. It is usually given as a 24 to 65% solution of the meglumine salt, or as a mixture of the sodium and meglumine salts; solutions of the sodium salt have also been used. Iodamide is no longer marketed in the US.
Originator
Sources: http://corporate.bracco.com/gb-en/history
Curator's Comment: In 1962 Bracco researchers develop the first original contrast agent from their in-house research, with reduced toxicity and high tolerability: iodamide.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ndrugs.com/?s=renovue-65 |
Diagnostic | RENOVUE-65 Approved UseUnknown Launch Date1978 |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
14.02 g × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644 |
9.8 g single, intravenous dose: 9.8 g route of administration: Intravenous experiment type: SINGLE co-administered: |
IODAMIDE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
2.58 g × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644 |
24.75 g single, intravenous dose: 24.75 g route of administration: Intravenous experiment type: SINGLE co-administered: |
IODAMIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
6.69 g × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644 |
61.82 g single, intravenous dose: 61.82 g route of administration: Intravenous experiment type: SINGLE co-administered: |
IODAMIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
16.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644 |
9.8 g single, intravenous dose: 9.8 g route of administration: Intravenous experiment type: SINGLE co-administered: |
IODAMIDE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1.29 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644 |
24.75 g single, intravenous dose: 24.75 g route of administration: Intravenous experiment type: SINGLE co-administered: |
IODAMIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
1.02 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644 |
61.82 g single, intravenous dose: 61.82 g route of administration: Intravenous experiment type: SINGLE co-administered: |
IODAMIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
Funbound
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
95% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644 |
24.75 g single, intravenous dose: 24.75 g route of administration: Intravenous experiment type: SINGLE co-administered: |
IODAMIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
95% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644 |
61.82 g single, intravenous dose: 61.82 g route of administration: Intravenous experiment type: SINGLE co-administered: |
IODAMIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.drugfuture.com/mt/meglumine-iodamide.pdf
24% or 65%
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28500
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB02724MIG
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | |||
|
CHEMBL1201239
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | |||
|
m6325
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | Merck Index | ||
|
29182
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | |||
|
31704
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | |||
|
100000086427
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | |||
|
C65929
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | |||
|
18656-21-8
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | |||
|
C014081
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | |||
|
DBSALT001393
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | |||
|
6X283535A3
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | |||
|
DTXSID90171915
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | |||
|
29455
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY | RxNorm | ||
|
242-480-6
Created by
admin on Fri Dec 15 16:28:49 GMT 2023 , Edited by admin on Fri Dec 15 16:28:49 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD